|
1
|
Yoon HI, Kwon OR, Kang KN, Shin YS, Shin
HS, Yeon EH, Kwon KY, Hwang I, Jeon YK, Kim Y and Kim CW:
Diagnostic value of combining tumor and inflammatory markers in
lung cancer. J Cancer Prev. 21:187–193. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McMillan DC: The systemic
inflammation-based Glasgow prognostic score: A decade of experience
in patients with cancer. Cancer Treat Rev. 39:534–540. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Osugi J, Muto S, Matsumura Y, Higuchi M,
Suzuki H and Gotoh M: Prognostic impact of the high-sensitivity
modified Glasgow prognostic score in patients with resectable
non-small cell lung cancer. J Cancer Res Ther. 12:945–951. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Spiekerman AM: Nutritional assessment
(protein nutriture). Anal Chem. 67:429R–436R. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Caccialanza R, Palladini G, Klersy C, Cena
H, Vagia C, Cameletti B, Russo P, Lavatelli F and Merlini G:
Nutritional status of outpatients with systemic immunoglobulin
light-chain amyloidosis 1. Am J Clin Nutr. 83:350–354. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rambod M, Kovesdy CP, Bross R, Kopple JD
and Kalantar-Zadeh K: Association of serum prealbumin and its
changes over time with clinical outcomes and survival in patients
receiving hemodialysis. Am J Clin Nutr. 88:1485–1494. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Devakonda A, George L, Raoof S, Esan A,
Saleh A and Bernstein LH: Transthyretin as a marker to predict
outcome in critically ill patients. Clin Biochem. 41:1126–1130.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ding H, Liu J, Xue R, Zhao P, Qin Y, Zheng
F and Sun X: Transthyretin as a potential biomarker for the
differential diagnosis between lung cancer and lung infection.
Biomed Rep. 2:765–769. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hao S, Sun S, Xiao X, He D and Liu L:
Selective expression of transthyretin in subtypes of lung cancer. J
Mol Histol. 47:239–247. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kawai H and Ota H: Low perioperative serum
prealbumin predicts early recurrence after curative pulmonary
resection for non-small-cell lung cancer. World J Surg.
36:2853–2857. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alifano M, Mansuet-Lupo A, Lococo F, Roche
N, Bobbio A, Canny E, Schussler O, Dermine H, Régnard JF, Burroni
B, et al: Systemic inflammation, nutritional status and tumor
immune microenvironment determine outcome of resected non-small
cell lung cancer. PLoS One. 9:e1069142014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Asamura H: Lung, pleural, and thymic
tumors. In: TNM Classification of Malignant Tumours. (8th edition.
Brierley JD, Gospodarowicz MK and Wittekind C (ed.) John Wiley
& Sons, Ltd., West Sussex). 105–118. 2017.
|
|
14
|
Sun X, Dyson HJ and Wright PE:
Fluorotryptophan incorporation modulates the structure and
stability of transthyretin in a site-specific manner. Biochemistry.
56:5570–5581. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kelly P, Paulin F, Lamont D, Baker L,
Clearly S, Exon D and Thompson A: Pre-treatment plasma proteomic
markers associated with survival in oesophageal cancer. Br J
Cancer. 106:955–961. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han WX, Chen ZM, Wei ZJ and Xu AM:
Preoperative pre-albumin predicts prognosis of patients after
gastrectomy for adenocarcinoma of esophagogastric junction. World J
Surg Oncol. 14:2792016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fujii T, Sutoh T, Morita H, Katoh T,
Yajima R, Tsutsumi S, Asao T and Kuwano H: Serum albumin is
superior to prealbumin for predicting short-term recurrence in
patients with operable colorectal cancer. Nutr Cancer.
64:1169–1173. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen J, Chen LJ, Xia YL, Zhou HC, Yang RB,
Wu W, Lu Y, Hu LW and Zhao Y: Identification and verification of
transthyretin as a potential biomarker for pancreatic ductal
adenocarcinoma. J Cancer Res Clin Oncol. 139:1117–1127. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cai W, Kong W, Dong B, Zhang J, Chen Y,
Xue W, Huang Y, Zhou L and Huang J: Pretreatment serum prealbumin
as an independent prognostic indicator in patients with metastatic
renal cell carcinoma using tyrosine kinase inhibitors as first-line
target therapy. Clin Genitourin Cancer. 15:e437–e446. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Smyth MJ, Taniguchi M and Street SE: The
anti-tumor activity of IL-12: Mechanisms of innate immunity that
are model and dose dependent. J Immunol. 165:2665–2670. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu P, Shen H, Wang G, Zhang P, Liu Q and
Du J: Prognostic significance of systemic inflammation-based
lymphocyte-monocyte ratio in patients with lung cancer: Based on a
large cohort study. PLoS One. 9:e1080622014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Porrata LF, Ristow K, Colgan JP, Habermann
TM, Witzig TE, Inwards DJ, Ansell SM, Micallef IN, Johnston PB,
Nowakowski GS, et al: Peripheral blood lymphocyte/monocyte ratio at
diagnosis and survival in classical Hodgkin's lymphoma.
Haematologica. 97:262–269. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nishijima TF, Muss HB, Shachar SS, Tamura
K and Takamatsu Y: Prognostic value of lymphocyte-to-monocyte ratio
in patients with solid tumors: A systematic review and
meta-analysis. Cancer Treat Rev. 41:971–978. 2015. View Article : Google Scholar : PubMed/NCBI
|
